133 related articles for article (PubMed ID: 22069107)
1. Vascular endothelial growth factor (VEGF) - part 2: in endocrinology and oncology.
Kajdaniuk D; Marek B; Foltyn W; Kos-Kudła B
Endokrynol Pol; 2011; 62(5):456-64. PubMed ID: 22069107
[TBL] [Abstract][Full Text] [Related]
2. [Vascular endothelial growth factor (VEGF) in endocrinology and oncology].
Kajdaniuk D; Marek B; Fołtyn W; Kos-Kudła B
Endokrynol Pol; 2011; 62 Suppl 3():14-22. PubMed ID: 22161982
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor (VEGF) - part 1: in physiology and pathophysiology.
Kajdaniuk D; Marek B; Borgiel-Marek H; Kos-Kudła B
Endokrynol Pol; 2011; 62(5):444-55. PubMed ID: 22069106
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis in endocrine tumors.
Turner HE; Harris AL; Melmed S; Wass JA
Endocr Rev; 2003 Oct; 24(5):600-32. PubMed ID: 14570746
[TBL] [Abstract][Full Text] [Related]
5. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features.
Bunone G; Vigneri P; Mariani L; Butó S; Collini P; Pilotti S; Pierotti MA; Bongarzone I
Am J Pathol; 1999 Dec; 155(6):1967-76. PubMed ID: 10595926
[TBL] [Abstract][Full Text] [Related]
6. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
Pradeep CR; Sunila ES; Kuttan G
Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic Therapy for Diabetic Nephropathy.
Tanabe K; Maeshima Y; Sato Y; Wada J
Biomed Res Int; 2017; 2017():5724069. PubMed ID: 28835895
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor (VEGF), VEGF receptors expression and microvascular density in benign and malignant thyroid diseases.
Jebreel A; England J; Bedford K; Murphy J; Karsai L; Atkin S
Int J Exp Pathol; 2007 Aug; 88(4):271-7. PubMed ID: 17696908
[TBL] [Abstract][Full Text] [Related]
9. [Expression of vascular endothelial growth factor and its receptors in endometrial carcinoma].
Wang H; Chen G; Zhang B
Zhonghua Bing Li Xue Za Zhi; 2002 Oct; 31(5):391-5. PubMed ID: 12485477
[TBL] [Abstract][Full Text] [Related]
10. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.
Hicklin DJ; Ellis LM
J Clin Oncol; 2005 Feb; 23(5):1011-27. PubMed ID: 15585754
[TBL] [Abstract][Full Text] [Related]
11. [The role of vascular endothelial growth factor in angiogenesis and diabetic retinopathy].
Valiatti FB; Crispim D; Benfica C; Valiatti BB; Kramer CK; Canani LH
Arq Bras Endocrinol Metabol; 2011 Mar; 55(2):106-13. PubMed ID: 21584427
[TBL] [Abstract][Full Text] [Related]
12. Expression of VEGF and its receptors and angiogenesis in bone and soft tissue tumors.
Hara H; Akisue T; Fujimoto T; Imabori M; Kawamoto T; Kuroda R; Fujioka H; Yamamoto T; Doita M; Kurosaka M
Anticancer Res; 2006; 26(6B):4307-11. PubMed ID: 17201149
[TBL] [Abstract][Full Text] [Related]
13. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
Zhao Y; Adjei AA
Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
[TBL] [Abstract][Full Text] [Related]
14. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
15. Uncoupling of VEGF with endothelial NO as a potential mechanism for abnormal angiogenesis in the diabetic nephropathy.
Nakagawa T; Sato W; Kosugi T; Johnson RJ
J Diabetes Res; 2013; 2013():184539. PubMed ID: 24386643
[TBL] [Abstract][Full Text] [Related]
16. VEGF as a key mediator of angiogenesis in cancer.
Carmeliet P
Oncology; 2005; 69 Suppl 3():4-10. PubMed ID: 16301830
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.
Gunningham SP; Currie MJ; Han C; Turner K; Scott PA; Robinson BA; Harris AL; Fox SB
Cancer Res; 2001 Apr; 61(7):3206-11. PubMed ID: 11306510
[TBL] [Abstract][Full Text] [Related]
18. [VEGF, anti-vEGF and diseases].
Corvol P
Bull Acad Natl Med; 2008 Feb; 192(2):289-300; discussion 300-2. PubMed ID: 18819684
[TBL] [Abstract][Full Text] [Related]
19. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
Abu-Jawdeh GM; Faix JD; Niloff J; Tognazzi K; Manseau E; Dvorak HF; Brown LF
Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.
Caldwell RB; Bartoli M; Behzadian MA; El-Remessy AE; Al-Shabrawey M; Platt DH; Caldwell RW
Diabetes Metab Res Rev; 2003; 19(6):442-55. PubMed ID: 14648803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
